NCT05912101

Brief Summary

Hip fracture is a common cause of surgery, especially in elderly patients. Unilateral spinal anesthesia in hip fracture surgery can prevent the undesirable effects of spinal anesthesia due to sympathetic blockade. However, severe pain in hip fracture patients limits the positioning required for unilateral spinal anesthesia. The sedation and analgesia required to position patients with fractured hip remains inferior may cause respiratory depression, hemodynamic instability or postoperative cognitive impairment, especially in elderly patients. Lower extremity peripheral blocks can be used preoperatively to minimize the use of sedatives that may be required during positioning and to provide effective and safe analgesia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 11, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

November 14, 2023

Status Verified

June 1, 2023

Enrollment Period

10 months

First QC Date

June 11, 2023

Last Update Submit

November 12, 2023

Conditions

Keywords

Hip FractureUnilateral Spinal AnesthesiaPericapsular Nerve Group Block3-1 BlockSuprainguinal Fascia Iliaca Compartment BlockPain Management

Outcome Measures

Primary Outcomes (1)

  • Positional Pain in Unilateral Spinal Anesthesia

    Pain in the pre-block period and during unilateral spinal anesthesia positioning after the block will be evaluated by VAS score.

    30 minutes after the block is performed

Secondary Outcomes (7)

  • Position Quality in Unilateral Spinal Anesthesia

    30 minutes after the block is performed

  • The Necessity for Sedoanalgesia for Positional Pain in Unilateral Spinal Anesthesia

    30 minutes after the block is performed

  • Postoperative Pain

    Postoperative 2nd, 6th, 12th and 24th hours

  • The Time Until First Opiod Requirement

    Postoperative first 24-hour-period

  • Postoperative First 24-hour-period Total Opioid Consumption

    Postoperative first 24-hour-period

  • +2 more secondary outcomes

Study Arms (3)

Group 1 (PENG)

EXPERIMENTAL

A convex USG Probe (1-5 mHz) is placed transversely on the SIAS (Spina Iliaca Anterior Superior). The probe is then rotated 45 degrees and aligned with the pubic ramus. In this position, the iliopubic eminence, ilipsoas muscle-tendon, femoral artery and pectineus muscle are observed. A 100 mm 21G block needle (Stimuplex A®:B. Braun Melsungen AG, Japan) is inserted in-plane from lateral to medial to the musculofascial plane with the psoas tendon in front and the pubic ramus behind and the injection is performed.

Procedure: Pericapsular Nerve Group Block

Group 2 (S-FICB)

EXPERIMENTAL

A linear USG probe (7-13 mHz) is placed parasagittal to obtain an image of the SIAS. The probe is then shifted medially to identify the fascia iliaca, iliac muscle, internal oblique muscle and deep circumflex iliac artery. A 50 mm 21G block needle (Stimuplex A®:B. Braun Melsungen AG, Japan) is advanced in-plane from caudal to cephalic and injected between the fascia iliaca and iliac muscle.

Procedure: Suprainguinal Fascia Compartment Block

Group 3 (3-1)

EXPERIMENTAL

A linear USG probe (7-13 mHz) is placed at the level of the femoral fold and the femoral vein-arterial-nerve is visualized. The femoral nerve is located below the fascia iliaca. At this point, a 50 mm 21G block needle (Stimuplex A®:B. Braun Melsungen AG, Japan) is inserted in-plane from lateral to medial and injected lateral to the femoral nerve. After injection, pressure is applied distal to the needle entry site to spread the local anesthetic proximally in the nerve sheath.

Procedure: 3-1 Block

Interventions

A convex USG Probe (1-5 mHz) is placed transversely on the SIAS (Spina Iliaca Anterior Superior). The probe is then rotated 45 degrees and aligned with the pubic ramus. In this position, the iliopubic eminence, ilipsoas muscle-tendon, femoral artery and pectineus muscle are observed. A 100 mm 21G block needle (Stimuplex A®:B. Braun Melsungen AG, Japan) is inserted in-plane from lateral to medial to the musculofascial plane with the psoas tendon in front and the pubic ramus behind and the injection is performed.

Group 1 (PENG)

A linear USG probe (7-13 mHz) is placed parasagittal to obtain an image of the SIAS. The probe is then shifted medially to identify the fascia iliaca, iliac muscle, internal oblique muscle and deep circumflex iliac artery. A 50 mm 21G block needle (Stimuplex A®:B. Braun Melsungen AG, Japan) is advanced in-plane from caudal to cephalic and injected between the fascia iliaca and iliac muscle.

Group 2 (S-FICB)
3-1 BlockPROCEDURE

A linear USG probe (7-13 mHz) is placed at the level of the femoral fold and the femoral vein-arterial-nerve is visualized. The femoral nerve is located below the fascia iliaca. At this point, a 50 mm 21G block needle (Stimuplex A®:B. Braun Melsungen AG, Japan) is inserted in-plane from lateral to medial and injected lateral to the femoral nerve. After injection, pressure is applied distal to the needle entry site to spread the local anesthetic proximally in the nerve sheath.

Group 3 (3-1)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and over
  • American Society of Anesthesiologists Physical Status Classification(ASA) I,II and III
  • Fully oriented and able to cooperate
  • Consented to participate in the study by signing the informed consent form
  • Patients with hip fracture and planned unilateral surgery with spinal anesthesia

You may not qualify if:

  • Patients under 18 years of age
  • Refusal to participate
  • American Society of Anesthesiologists Physical Status Classification(ASA) IV-V
  • Non-cooperation
  • Coagulopathy or thrombocytopenia
  • Allergic to local anesthetics and analgesics
  • Patients with anatomical abnormalities or active infection at the points of application

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Bozyaka Training and Research Hospital

Izmir, Karabaglar, 35170, Turkey (Türkiye)

Location

Related Publications (3)

  • Giron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.

    PMID: 30063657BACKGROUND
  • Hebbard P, Ivanusic J, Sha S. Ultrasound-guided supra-inguinal fascia iliaca block: a cadaveric evaluation of a novel approach. Anaesthesia. 2011 Apr;66(4):300-5. doi: 10.1111/j.1365-2044.2011.06628.x. Epub 2011 Feb 24.

    PMID: 21401544BACKGROUND
  • Winnie AP, Ramamurthy S, Durrani Z. The inguinal paravascular technic of lumbar plexus anesthesia: the "3-in-1 block". Anesth Analg. 1973 Nov-Dec;52(6):989-96. No abstract available.

    PMID: 4796576BACKGROUND

MeSH Terms

Conditions

Hip FracturesAgnosiaPain, Postoperative

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2023

First Posted

June 22, 2023

Study Start

January 1, 2023

Primary Completion

November 1, 2023

Study Completion

December 1, 2023

Last Updated

November 14, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations